MNKD
Mannkind Corporation
stockNASDAQ
At CloseNov 13, 2026 3:59:57 PM EST
4.12USD-0.962%(-0.04)1,686,725
Pre-marketNov 13, 2026 8:56:30 AM EST
4.23USD+1.683%(+0.07)
After-hoursNov 13, 2026 4:00:30 PM EST
4.13USD+0.243%(+0.01)
Loading…
Loading…
1.33B
Healthcare
Biotechnology
CEO
Michael Castagna
HQ
Danbury, CT, USA
250
Previous Close
$4.16
Beta
1.06
52-Week High
$6.51 2026-01-08
52-Week Low
$2.23 2026-03-27
SMA 50
$3.57
SMA 200
$3.66
Avg. Vol 10D
4.02M
Avg. Vol 30D
3.74M
Avg. Vol 90D
4.25M
Relative Vol
0.37
321.64M
307.06M
95.47%
26,220,516
8.54%
10.31
57%/43%
48.65%
33.46%
0.4100%
9,700,000
12,471
5,248
12,471
Mar 3, 2017 · 1-for-5 (reverse)
413.4M
-74.8M
-78.4M
-2.88
182.9
Nov 10, 2026
MannKind to Participate in Upcoming Investor Conferences · 
GlobeNewswire Inc.
Nov 6, 2026
MannKind (MNKD) Q3 2026 Earnings Call Transcript · 
The Motley Fool+1 source
MNKD Profile
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
MNKD Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.90 | 2026-11-06 | +5.64% | 2.085 |
| 1M | 3.05 | 2026-10-13 | +35.08% | 1.351 |
| 3M | 3.73 | 2026-08-13 | +10.46% | 0.919 |
| 6M | 3.21 | 2026-05-13 | +28.35% | 1.073 |
| 1Y | 5.07 | 2025-11-13 | -18.74% | 1.061 |
| 2Y | 6.96 | 2024-11-13 | -40.80% | — |
| 5Y | 4.99 | 2021-11-12 | -17.43% | 1.077 |
MNKD Stock Summary
Mannkind Corporation (NASDAQ:MNKD) stock price today is $4.12, and today's volume is 1,374,621. MNKD is down 0.962% today. The 30 day average volume is 3.74M. MNKD market cap is $1.33B with 321.64M shares outstanding.